MILLENNIUM MANAGEMENT LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,863,748
+94.3%
275,785
+43.5%
0.00%
+100.0%
Q2 2023$1,988,525
+60562.8%
192,128
-45.8%
0.00%
-50.0%
Q1 2023$3,278
+33.3%
354,776
+28.0%
0.00%
+100.0%
Q4 2022$2,459
-99.9%
277,248
-36.9%
0.00%
-50.0%
Q3 2022$3,657,000
-27.5%
439,522
-28.7%
0.00%
-33.3%
Q2 2022$5,047,000
+269.2%
616,245
+292.8%
0.00%
+200.0%
Q1 2022$1,367,000
+112.9%
156,904
+132.5%
0.00%
Q4 2021$642,000
-44.4%
67,492
-1.7%
0.00%
-100.0%
Q3 2021$1,155,000
+18.6%
68,687
+7.7%
0.00%0.0%
Q2 2021$974,000
-32.6%
63,800
-14.0%
0.00%0.0%
Q1 2021$1,445,000
+12.1%
74,201
+3.7%
0.00%0.0%
Q4 2020$1,289,000
-25.5%
71,522
-20.3%
0.00%
-50.0%
Q3 2020$1,730,000
-37.7%
89,708
-15.6%
0.00%
-50.0%
Q2 2020$2,776,000
+976.0%
106,279
+879.1%
0.00%
Q3 2019$258,000
-92.1%
10,855
-88.0%
0.00%
-100.0%
Q2 2019$3,248,000
-12.0%
90,368
-9.5%
0.01%
-16.7%
Q1 2019$3,690,000
-22.0%
99,894
-9.1%
0.01%
-14.3%
Q4 2018$4,732,000
-57.1%
109,892
-52.9%
0.01%
-50.0%
Q3 2018$11,021,000
+28.5%
233,353
+35.4%
0.01%
+27.3%
Q2 2018$8,575,000
+8.5%
172,332
+8.3%
0.01%0.0%
Q1 2018$7,906,000
+1751.5%
159,113
+1285.4%
0.01%
+1000.0%
Q4 2017$427,00011,4850.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders